Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/02/2003EP0983037B1 Antifungal nail lacquer
05/02/2003EP0979081A4 Composition and methods using an eutomer
05/02/2003EP0969834B1 Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
05/02/2003EP0968221B1 Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions
05/02/2003EP0967980B1 Use of aminothiazoles for treating wounds and skin
05/02/2003EP0963371B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
05/02/2003EP0934939B1 Neuraminic acid compounds
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/02/2003EP0910563B1 Integrin receptor antagonists
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0881903B1 Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
05/02/2003EP0879294B1 Transduced human hematopoietic stem cells
05/02/2003EP0876146B1 Nucleoside analogs in combination therapy of herpes simplex infections
05/02/2003EP0869796B1 A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii
05/02/2003EP0868184B1 Sustained-release microgranules containing diltiazem as the active principle
05/02/2003EP0854874B1 Macrocyclic lactone compounds and their production process
05/02/2003EP0831837B1 Use of squalamine for the manufacture of a medicament for inhibiting nhe
05/02/2003EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/02/2003EP0801562B1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
05/02/2003EP0800584B1 Arachidonic acid and methods for the production and use thereof
05/02/2003EP0797439B1 Use of pramipexole as a neuroprotective agent
05/02/2003EP0793491B1 Pharmaceutical compositions comprising lycopene
05/02/2003EP0786988B1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/2003EP0777483B1 Methods and means for drug administration
05/02/2003EP0775130B1 Method for the preparation of (+/-)-calanolide a and intermediates thereof
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/02/2003EP0772592B1 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS
05/02/2003EP0738150B1 Bicyclic fibrinogen antagonists
05/02/2003EP0738146B1 Method of treating disorders of the animal or human body by administering amino acids
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003EP0715519B1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
05/02/2003EP0706396B1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
05/02/2003EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES
05/02/2003EP0581849B1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035886A2 Method for preparing heparin from mast cell cultures
05/01/2003WO2003035876A1 Use of a double strand ribonucleic acid for treating an infection with a positive-strand rna-virus
05/01/2003WO2003035870A1 Drug for treating a carcinoma of the pancreas
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035836A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
05/01/2003WO2003035790A2 Improved method for generating an aerosol
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
05/01/2003WO2003035666A2 Phosphorothioate-modified oligonucleotide as anti-restenosis agent
05/01/2003WO2003035665A1 Modified l-nucleic acid
05/01/2003WO2003035663A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
05/01/2003WO2003035661A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
05/01/2003WO2003035659A1 Acarbose purification process
05/01/2003WO2003035654A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003WO2003035653A1 Pyridothienopyrimidine compound and salt thereof
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035649A1 Imidazopyridine compounds as 5-ht4 receptor modulators
05/01/2003WO2003035648A1 Aryl substituted oxazolidinones with antibacterial activity
05/01/2003WO2003035646A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035640A1 Pyrimidone compounds and pharmaceutical compositions containing the same
05/01/2003WO2003035639A1 Pyrimidine compound and medicinal composition thereof
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035629A1 Thiopene- amd thiazolesulfonamides as antineoplastic agents
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035623A1 Method of resolving amlodipine racemate
05/01/2003WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035603A1 Acetic acid derivatives
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents
05/01/2003WO2003035510A1 Transdermal/transmucosal patch packaging
05/01/2003WO2003035237A2 Compounds for use as surfactants
05/01/2003WO2003035178A1 Methods and compositions for modulating alpha adrenergic receptor activity
05/01/2003WO2003035177A2 Optimal polymer mixtures for gastric retentive tablets
05/01/2003WO2003035137A2 Method and apparatus for dispensing inhalator medicament
05/01/2003WO2003035135A1 Optimized dosing for drug coated stents
05/01/2003WO2003035133A1 Stents
05/01/2003WO2003035111A1 Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
05/01/2003WO2003035109A1 Remedies for pruritus
05/01/2003WO2003035108A1 Immunopotentiators in thermotherapy for cancer
05/01/2003WO2003035107A1 Enzyme inhibitors for inactivating allergens
05/01/2003WO2003035103A1 Anti-tumor chemotherapy by administration of cyclophosphamide and erythropoeitin
05/01/2003WO2003035098A1 Method for re-sensitizing vancomycin resistant bacteria using agents which selectively cleave a cell wall depsipeptide
05/01/2003WO2003035095A1 Use of histamine to treat liver disease
05/01/2003WO2003035089A1 Preventives/remedies for foot and mouth disease
05/01/2003WO2003035086A1 Formulation
05/01/2003WO2003035083A1 Drug for treating a fibrotic disease through rna interfence
05/01/2003WO2003035082A1 Drug for inhibiting expression of a target gene
05/01/2003WO2003035081A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
05/01/2003WO2003035080A2 A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
1 ... 5482 5483 5484 5485 5486 5487 5488 5489 5490 5491 5492 5493 5494 5495 5496 5497 5498 5499 5500 5501 5502 ... 7860